Intramolecular isomünchnone cycloaddition approach to the antitumor agent camptothecin

A novel, convergent approach to the antitumor agent camptothecin has been developed with a rhodium (II)-catalyzed intramolecular [3+2] cycloaddition as the key step.

Figure optionsDownload as PowerPoint slide